Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.
M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs
Year: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1982 | 1967 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 3 | 5 | 7 | 15 | 15 | 11 | 14 | 13 | 8 | 15 | 13 | 19 | 117 | 9 | 16 | 19 | 25 | 23 | 18 | 25 | 26 | 25 | 26 | 43 | 38 | 61 | 46 | 42 | 60 | 68 | 81 | 67 | 68 | 38 | 27 | 38 | 21 | 8 | 1 | 1 | 1177 |
Title and authors | Publication | Year |
---|---|---|
Risk of postprandial insulin resistance: The liver/vagus rapport
MP Macedo, IS Lima, JM Gaspar, RA Afonso, RS Patarrão, YB Kim, RT Ribeiro |
Reviews in Endocrine and Metabolic Disorders | 2013 |
Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor α in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity
JS Ross, W Hu, B Rosen, AJ Snider, LM Obeid, LA Cowart |
The Journal of biological chemistry | 2013 |
Extracts of Rhizoma polygonati odorati prevent high-fat diet-induced metabolic disorders in C57BL/6 mice
M Gu, Y Zhang, S Fan, X Ding, G Ji, C Huang |
PloS one | 2013 |
Hypertension in Metabolic Syndrome: Vascular Pathophysiology
Y Mendizábal, S Llorens, E Nava |
International Journal of Hypertension | 2013 |
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen |
Nutritional Management of Renal Disease | 2013 |
Progression of cardiovascular and endocrine dysfunction in a rabbit model of obesity
GA Eppel, JA Armitage, N Eikelis, GA Head, RG Evans |
Hypertension Research | 2013 |
Hypertension in obesity: is leptin the culprit?
SE Simonds, MA Cowley |
Trends in Neurosciences | 2013 |
Anti-obesity and hypolipidaemic effects of Nelumbo nucifera seed ethanol extract in human pre-adipocytes and rats fed a high-fat diet: Anti-obesity and hypolipidaemic effects of Nelumbo nucifera seed ethanol extract
JS You, YJ Lee, KS Kim, SH Kim, KJ Chang |
Journal of the Science of Food and Agriculture | 2013 |
Impaired fasting glucose as an independent risk factor for hypertension among healthy middle-aged Japanese subjects with optimal blood pressure: the Yuport Medical Checkup Centre retrospective cohort study
M Morio, M Inoue, K Inoue, K Akimoto |
Diabetology & metabolic syndrome | 2013 |
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
C Hales, D Barker |
International Journal of Epidemiology | 2013 |
Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats
C Tomaro-Duchesneau, S Saha, M Malhotra, ML Jones, A Labbé, L Rodes, I Kahouli, S Prakash |
Applied Microbiology and Biotechnology | 2013 |
Extracts of Rhizoma Polygonati Odorati Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice
M Gu, Y Zhang, S Fan, X Ding, G Ji, C Huang, H Waki |
PloS one | 2013 |
Renoprotective strategies in lupus nephritis: beyond immunosuppression
B Griffin, L Lightstone |
Lupus | 2013 |